Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

1 Receptor Agonist Product Portfolios and R&D Pipelines

 

4 ) Interferon

a) INTERFERON alpha

 

• Interferon alpha sales 2012 of branded products in regulated markets

• 1st generation Interferon alpha-2a in regulated markets

• 1st generation Interferon alpha-2a in non-regulated markets

• Next generation Interferon alpha-2a in regulated markets

• Next generation Interferon alpha-2a in non-regulated markets and biosimilars

• 1st generation Interferon alpha-2b in regulated markets

• 1st generation Interferon alpha-2b in non-regulated markets and biosimilars

• Next generation Interferon alpha-2b in regulated markets

• Next generation Interferon alpha-2b in non-regulated markets and biosimilars

• Other Interferon alpha sub-types

• Interferon alpha with not specified sub-type – 1/2

• Purified natural human interferon alpha

 

b) Consensus INTERFERONs

c) INTERFERON beta

 

• Interferon beta sales 2012 of branded products in regulated markets

• 1st generation Interferon beta-1a in regulated markets

• 1st generation Interferon beta-1a in non-regulated markets and biosimilars

• 1st generation Interferon beta-1b in regulated markets

• 1st generation Interferon beta-1b in non-regulated markets and biosimilars

• 1st generation Interferon beta with not disclosed sub-type

• Next generation Interferon beta in regulated markets

• Purified natural human interferon beta

 

d) INTERFERON gamma

e) Other INTERFERONs

5 ) Insulin

 

• 2012 Sales of branded recombinant human insulins in regulated markets

• 2012 Sales of branded short-acting recombinant human insulin analogs in regulate
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Md. , Oct. 22, 2014   Synthetic ... developing novel pathogen-specific therapies for serious infections and diseases, ... has issued a Notice of Allowance for a composition ... its C. difficile program, SYN-004. This is ... SYN-004 in the U.S. and adds to the Company,s ...
(Date:10/20/2014)... 2014 The report “Pharmacy Automation ... Packaging and Labeling Systems, Table-top Counters) by End-user ... Forecasts & Trends to 2019” analyzes and studies ... North America, Europe, Asia-Pacific, and the Rest of ... and 30 figures spread through 300 pages and ...
(Date:10/20/2014)... , A major pan-European survey into the ... care has revealed changing trends in many important GI ... of healthcare services across the continent. The results of ... (UEG), have been announced today and led to calls ... of GI disorders across Europe ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy ... of donor stem cells for dogs with osteoarthritis. Dr. ... has performed clinical stem cell therapy for 7 years. ... if a single injection of donor stem cells into ... pain and inflammation in the treated joints. , ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... ... than men when treated with minimally invasive endovascular therapy. Two years after endovascular treatment, ... study of 277 patients. , ... (PRWEB) January 18, 2010 -- Women who are at risk of lower-leg amputation fare ...
... global sources of protein and oil, is now the ... sequence. The sequence and its analysis appear in ... . The research team comprised 18 institutions, including ... JGI), the U.S. Department of Agriculture-Agricultural Research Service (USDA-ARS), ...
... AUSTIN, Texas, Jan. 7 Bender Consulting, a premier boutique ... merger and acquisition (M&A) related activity that will have the ... Bender Consulting combines proven industry experts and world-class consulting resources ... Bio Tech clients. The talent at Bender Consulting has been ...
Cached Biology Technology:Women More Likely Than Men to Avoid Amputation After Minimally Invasive Therapy for Blocked Leg Arteries 2Women More Likely Than Men to Avoid Amputation After Minimally Invasive Therapy for Blocked Leg Arteries 3Soybean genome analysis reveals pathways for improving biodiesel 2Soybean genome analysis reveals pathways for improving biodiesel 3Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 2Bender Consulting Predicts Key Trends and Merger and Acquisition Activity for the Oil & Gas Sector in 2010 3
(Date:10/17/2014)... Researchers from the University of Copenhagen have shown for ... the lungs of Cystic fibrosis patients, giving them the ... growth in chronic infections. , The study also discovered ... fibrosis (CF) patients was halted or slowed down by ... consumed all the oxygen and helped "suffocate" the bacteria, ...
(Date:10/16/2014)... researchers have challenged conventional thinking on how the bowel ... mechanism for how bowel cancer starts. , The researchers ... and regenerating the ,crypts, that are a feature of ... involved in bowel cancer development, a controversial finding as ... , Using 3D imaging technologies, Dr Chin Wee Tan ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2Sandata Announces Case Study with Quality Care Services, Inc. 2
... rainforests of Panama provides an unprecedented level of detail ... the soil to the forest canopy. Yves Basset, scientific ... Tropical Research Institute, led an international team on Project ... a 6,000 hectare forest hosts a total of around ...
... Alberta archeologist may lead to a rethinking of how, ... U of A researcher and anthropology chair Pamela Willoughby,s ... fossils and other evidence that records the beginnings of ... in the journal Quaternary International , may be ...
... New Rochelle, NY, December 13A leading scientific society of ... and research in the sciences and technologies of environmental ... Professors (AEESP) , has selected the peer-reviewed journal ... Journal. Environmental Engineering Science is read around ...
Cached Biology News:More bang for bugs 2Tracing humanity's African ancestry may mean rewriting 'out of Africa' dates 2Tracing humanity's African ancestry may mean rewriting 'out of Africa' dates 3Association of Environmental Engineering and Science Professors name Environmental Engineering Science as its official journal 2
...
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
... Tetrad 2 thermal cycler is a completely ... Tetrad chassis, and it accepts the full ... delivers the same precision in thermal performance ... Tetrad thermal cyclers, allowing easy transport of ...
... includes 2 tube gel adaptors, 24 ... length), gaskets, grommets, stoppers. The PROTEAN II ... cell offer the versatility to perform a ... second-dimension 2-D electrophoresis, native, preparative, and gradient ...
Biology Products: